Preface
Authors:
- Jeffrey CummingsJCJeffrey Cummings
- R. Michael PooleRPR. Michael Poole
- Michael P. McDermottMMMichael P. McDermott
- J. Todd ArnedtJAJ. Todd Arnedt
- Nazem AtassiNANazem Atassi
- Judith BebchukJBJudith Bebchuk
- Devin L. BrownDBDevin L. Brown
- Rickey E. CarterRCRickey E. Carter
- Rick ChappellRCRick Chappell
- William R. ClarkeWCWilliam R. Clarke
- Christopher S. CoffeyCCChristopher S. Coffey
- Peter G. ComoPCPeter G. Como
Editor:
- Michael PooleMPMichael Poole
- 5 May 2012
- book
- Published by Cambridge University Press (CUP)
Abstract
Translating laboratory discoveries into successful therapeutics can be difficult. Clinical Trials in Neurology aims to improve the efficiency of clinical trials and the development of interventions in order to enhance the development of new treatments for neurologic diseases. It introduces the reader to the key concepts underpinning trials in the neurosciences. This volume tackles the challenges of developing therapies for neurologic disorders from measurement of agents in the nervous system to the progression of clinical signs and symptoms through illustrating specific study designs and their applications to different therapeutic areas. Clinical Trials in Neurology covers key issues in Phase I, II and III clinical trials, as well as post-marketing safety surveillance. Topics addressed include regulatory and implementation issues, outcome measures and common problems in drug development. Written by a multidisciplinary team, this comprehensive guide is essential reading for neurologists, psychiatrists, neurosurgeons, neuroscientists, statisticians and clinical researchers in the pharmaceutical industry.Keywords
This publication has 96 references indexed in Scilit:
- Funding of US Biomedical Research, 2003-2008JAMA, 2010
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled TrialJAMA, 2009
- Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase IIIAnnals of Neurology, 2009
- Sample size re‐estimation in clinical trialsBiometrical Journal, 2009
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson DiseaseArchives of Neurology, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004